Latka logo
Soluscope logo

Soluscope

Aubagne, France

2021 Revenue

$2.4M

Funding

$0

Team

88

Founded

1994

Soluscope Revenue (2021)

Soluscope generated $2.4M in revenue in 2021.

Provider of endoscope reprocessing services. The company's products and service include automatic reprocessors, dedicated chemistry, transport, storage and drying devices as well as data management software.

Last updated

Soluscope Revenue

In 2021, Soluscope's revenue reached $2.4M.

Soluscope Revenue GrowthReported revenue / ARR over time$0$600K$1.2M$1.8M$2.4M$3M199419961998200020022004200620082010201220142016201820202021$0$2.4MSource: GetLatka.com
YearMilestoneSource
2021Soluscope Hit $2.4m revenue in April 2021Not recorded
1994Launched with $0 revenue

Founder / CEO

Jean-Francois Biry

CEO

Prior to joining Soluscope, Jean-François Biry headed the biotechnology company DBV Technologies, which specialized in food allergies, where he raised over €18 million. Before that, he was Vice-President of Cider Santé, a listed group of outsourced services to the pharmaceutical industry as well as General Manager of Edmond de Rothschild group holdings in France. Mr. Biry is a graduate of IEP in Paris and ESCP Europe.

Soluscope Employees & Team Size

Soluscope employs approximately 88 people as of 2026.

Soluscope Team GrowthReported headcount over time020406080100199419961998200020022004200620082010201220142016201820202021008888Source: GetLatka.com
YearMilestoneSource
2021Reached 88 employees (April 2021)Not recorded

Frequently Asked Questions about Soluscope

Is Soluscope still an independent company?

No. Soluscope was acquired by Laboratoires Anios.

What is Soluscope's revenue?

As of 2021, Soluscope generated $2.4M in revenue.

Who founded Soluscope?

Soluscope was founded by Jean-Francois Biry.

How many employees does Soluscope have?

As of 2021, Soluscope had 88 employees.

Where is Soluscope headquartered?

Soluscope is headquartered in Aubagne, France.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile